+44 (0) 20 7549 9987 | USA callers: 00-1-718-682-4567

Contact Us Now

“Medical Device Compliant Management Services Market Worth $576.34 Million in 2019”, says Visiongain report

08 January 2020
Pharma

Visiongain’s new report the Medical Device Compliant Management Services Market Report 2019-2029: Forecasts by Service (Complaints Log {Receive Complaints, Classify Issue, Record Issue}, Product Surveillance & Regulatory Compliance {Reportable/Non Reportable, Medical Device Vigilance/Medical Device Reporting, Field Action}, Returned/ Non-Returned Product Analysis {Complaint Investigation, Root Cause Testing, Preventive Action}, Resolve Log { Complaint Summary, Customer Letter Creation}), plus analysis of leading companies indicates that the global Medical Device Compliant Management Services market will attain $1,236.4 million revenue by 2029.

Global Medical Device Compliant Management Services market is expected to grow on account of the adoption of digitization and artificial intelligence in the healthcare system for data maintenance and manage customer complaints in a timely manner. The market is expected to grow at a healthy CAGR of 7.9% over the projected period. In addition, the usage of compliant management services to improve the complaint process and provide high-quality feedback to customers is expected to spur the growth of Medical Device Compliant Management Services over the projected period.

Furthermore, complaint management services assist the medical device companies to make continuous improvements in regulatory compliance, user safety, and customer satisfaction by establishing a distinctive complaint handling process. Also, regulatory bodies around the globe emphasize the importance of complaint handling system for medical device companies. According to USFDA regulation, a complaint file should be retained for each device introduced in the market and a formal complaint handling unit should be designated by manufacturers.

It is also discovered that even with the well-defined requirements from various regulatory bodies; there is a large number of complaints recorded every year and it keeps on increasing. Implementing an efficient complaint handling method is a challenge for most organizations, particularly when products are sold in different regions. Having a flexible and effective method of managing complaints helps organizations to be effective and assist in sustaining the market for a longer period of time.

In 2019, North America Medical Device Compliant Management Services market accounted for the majority of the global market. The growth of the North American market is attributed to growing regulatory scenario and heavy monetary fines for non-compliance on medical device manufacturers, importers, and distributors by a respective regulatory body.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2022-2032

The global Contract Research Organizations (CROs) market was valued at US$57.1 billion in 2021 and is projected to grow at a CAGR of 9.95% during the forecast period 2022-2032.

12 August 2022

Read

Visiongain Publishes Genome Editing Technologies Market Report 2022-2032

The Global Genome Editing Technologies market is estimated to be valued at US$ 4,225.48 million in 2022. The market is projected to reach a market value of US$ 18,570.41 million by 2032. We predict strong revenue growth through to 2032.

02 August 2022

Read

Visiongain Publishes Synthetic Biology Market Report 2022-2032

The global synthetic biology market was valued at US$13.8 billion in 2021 and is projected to grow at a CAGR of 25.52% during the forecast period 2022-2032.

27 July 2022

Read

Visiongain Publishes Biosimilar Monoclonal Antibodies Market Report 2022-2032

The global biosimilar monoclonal antibodies market was valued at US$4,087 million in 2021 and is projected to grow at a CAGR of 23.5% during the forecast period 2022-2032.

25 July 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever